Press Release

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Cell and gene therapy industry continues to expand manufacturing infrastructure in the UKCell and gene therapy industry continues to expand manufacturing infrastructure in the UKCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesHsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorHsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureCell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesPlurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingPress ReleaseUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive Directors£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadership£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapies